Verde Capital Management Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Verde Capital Management trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 694 shares of the healthcare conglomerate’s stock after selling 110 shares during the period. Verde Capital Management’s holdings in UnitedHealth Group were worth $406,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter worth $27,000. Macroview Investment Management LLC grew its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares in the last quarter. Delos Wealth Advisors LLC lifted its stake in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.6 %

NYSE:UNH opened at $569.61 on Friday. The stock has a fifty day moving average price of $584.42 and a 200 day moving average price of $534.15. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The firm has a market cap of $524.26 billion, a PE ratio of 34.82, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. Barclays raised their target price on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Bank of America dropped their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.